A2 Biotherapeutics, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for A2 Biotherapeutics, Inc..The latest application filed is for "lilrb1-based chimeric antigen receptor".
- A2 Biotherapeutics, Inc. - Agoura Hills CA US
Trademarks
| Patent | Date |
|---|---|
| Lilrb1-based Chimeric Antigen Receptor App 20220289818 - Kamb; Carl Alexander ; et al. | 2022-09-15 |
| Compositions and methods for treating ceacam positive cancers Grant 11,433,100 - Wang , et al. September 6, 2 | 2022-09-06 |
| Compositions And Methods For Treating Egfr Positive Cancers App 20220273721 - OH; Julyun ; et al. | 2022-09-01 |
| Lilrb1-based Chimeric Antigen Receptor App 20220162287 - KAMB; Carl Alexander ; et al. | 2022-05-26 |
| Lilrb1-based Chimeric Antigen Receptor App 20220153807 - KAMB; Carl Alexander ; et al. | 2022-05-19 |
| Engineered Immune Cells That Modulate Receptor Expression App 20220089674 - Kamb; Alexander | 2022-03-24 |
| Engineered Immune Cells With Dominant Signals App 20220089675 - Kamb; Alexander | 2022-03-24 |
| Engineered Immune Cells With Receptor Signal Strength Modulated By A Hinge App 20220089676 - Kamb; Alexander | 2022-03-24 |
| Engineering Immune Cells Based On Antigen Levels App 20220090013 - Kamb; Alexander | 2022-03-24 |
| Controlling Proximity Of Immune Cell Receptors App 20220090017 - Kamb; Alexander | 2022-03-24 |
| Engineered Immune Cells With Micro-clusters App 20220090016 - Kamb; Alexander | 2022-03-24 |
| Engineered Immune Cells With Multiplex And Localized Activity App 20220090015 - Kamb; Alexander | 2022-03-24 |
| Engineered Immune Cells With Receptor Cross-talk App 20220090014 - Kamb; Alexander | 2022-03-24 |
| Compositions And Methods For Treating Ceacam Positive Cancers App 20220054551 - WANG; Xueyin ; et al. | 2022-02-24 |
| LILRB1-based chimeric antigen receptor Grant 11,254,726 - Kamb , et al. February 22, 2 | 2022-02-22 |
| Lilrb1-based Chimeric Antigen Receptor App 20210230247 - KAMB; Carl Alexander ; et al. | 2021-07-29 |
| SEC | 0001828750 | A2 Biotherapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 